Event Videos

https://www.ncbi.nlm.nih.gov/pubmed/31574857 Tyrosinemia
Medicine (Baltimore). 2019 Sep;98(39):e17303. doi: 10.1097/MD.0000000000017303.
Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain.
Couce ML1, Sánchez-Pintos P1, Aldámiz-Echevarría L2, Vitoria I3, Navas V4, Martín-Hernández E5, García-Volpe C6, Pintos G7, Peña-Quintana L8, Hernández T9, Gil D10, Sánchez-Valverde F11, Bueno M12, Roca I1, López-Ruzafa E13, Díaz-Fernández C14.

Abstract

Published on: 
Sep-2019

https://www.ncbi.nlm.nih.gov/pubmed/31436707 Chronic liver disease

J Pediatr Gastroenterol Nutr. 2019 Jul 10. doi: 10.1097/MPG.0000000000002443. [Epub ahead of print]

Nutrition Support of Children with Chronic Liver Diseases: A Joint Position Paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Mouzaki M1, Bronsky J2, Gupte G3, Hojsak I4, Jahnel J5, Pai N6, Quiros-Tejeira RE7, Wieman R1, Sundaram S8.

Published on: 
Aug-2019

https://www.ncbi.nlm.nih.gov/pubmed/31436896 Liver transplant
Clin Transplant. 2019 Aug 22. doi: 10.1111/ctr.13698. [Epub ahead of print]
Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus.
Vondrak K1, Parisi F2, Dhawan A3, Grenda R4, Webb NJ5, Marks SD6, Debray D7, Holt RC8, Lachaux A9, Kelly D10, Kazeem G11,12, Undre N11.

Abstract

BACKGROUND AND AIMS:
This multicenter trial compared immediate-release tacrolimus (IR-T) versus prolonged-release tacrolimus (PR-T) in de novo kidney-, liver-, and heart-transplant recipients aged <16 years. Each formulation had similar pharmacokinetic (PK) profiles. Follow-up efficacy and safety results are reported herein.

MATERIALS AND METHODS:

Published on: 
Aug-2019

https://www.ncbi.nlm.nih.gov/pubmed/31423562 Chronic liver disease
Indian J Gastroenterol. 2019 Aug 19. doi: 10.1007/s12664-019-00960-9. [Epub ahead of print]

Non-endoscopic predictors of esophageal varices in children with chronic liverdisease and their utility in resource-constrained countries.

Alam R1, Karim ASMB2, Rukunuzzaman M2, Yasmin A2, Hossen K2, Benzamin M2.

Author information
1
Department of Pediatric Gastroenterology and Nutrition, Bangabandhu Sheikh Mujib Medical University, Dhaka, 1000, Bangladesh.
2
Department of Pediatric Gastroenterology and Nutrition, Bangabandhu Sheikh Mujib Medical University, Dhaka, 1000, Bangladesh.

Abstract

BACKGROUND:

Published on: 
Aug-2019

https://www.ncbi.nlm.nih.gov/pubmed/31444465 NAFLD
Eur J Clin Nutr. 2019 Aug 23. doi: 10.1038/s41430-019-0493-y. [Epub ahead of print]
Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease.
Yodoshi T1, Orkin S1, Arce-Clachar AC1,2, Bramlage K1, Liu C3, Fei L2,3, El-Khider F4, Dasarathy S4, Xanthakos SA1,2, Mouzaki M5,6.

Abstract

BACKGROUND/OBJECTIVES:
To determine associations between serum 25-hydroxyvitamin D (25(OH)-D) concentrations and histologic nonalcoholic fatty liver disease (NAFLD) severity.

SUBJECTS/METHODS:

Published on: 
Aug-2019

https://www.ncbi.nlm.nih.gov/pubmed/31450232 cholestasis
Pediatr Res. 2019 Aug 26. doi: 10.1038/s41390-019-0548-8. [Epub ahead of print]
Molecular findings in children with inherited intrahepatic cholestasis.
Wang NL1, Lu Y1, Gong JY2, Xie XB1, Lin J3, Abuduxikuer K1, Zhang MH2, Wang JS4.

Abstract

BACKGROUND:
Genetic defects account for a substantial proportion of pediatric cholestasis. This study explored the molecular findings in a large cohort of Chinese patients with inherited cholestasis.

METHODS:
Between January 2012 and June 2016, 809 Chinese pediatric patients with suspected inherited intrahepatic cholestasis were evaluated by Sanger sequencing and/or panel sequencing.

RESULTS:

Published on: 
Aug-2019

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: